NCT00212719|CompletedPhase 3
Loading search results
Sponsor study identifier
interventional
250
0 countries
N/A
Study Start
May 2003
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
April 2006
Actual (reported)Study Completion
Not reported
Date not reportedThe purpose of this study is to evaluate the efficacy and safety of ONO-5920 in patients with involutional osteoporosis.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
Not reported
Date not reportedClick on a node to explore related trials.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
May 2003
Date type not reportedThis date has not been verified as actual or estimated.
September 13, 2005
Actual (reported)September 21, 2005
Actual (reported)April 2006
Actual (reported)Mean bone mineral density of the lumbar spine (L2-4 BMD)
Bone mineral density at femur, fragility fractures, biochemical markers of bone turnover, lower back pain
Hagino H, Nishizawa Y, Sone T, Morii H, Taketani Y, Nakamura T, Itabashi A, Mizunuma H, Ohashi Y, Shiraki M, Minamide T, Matsumoto T. A double-blinded head-to-head trial of minodronate and alendronate in women with postmenopausal osteoporosis. Bone. 2009 Jun;44(6):1078-84. doi: 10.1016/j.bone.2009.02.016. Epub 2009 Mar 2.
Project Leader, ' Development Planning
Ono Pharmaceutical Co., Ltd.
First Submitted
September 13, 2005
First Posted
September 21, 2005
Study Start
May 2003
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
April 2006
Actual (reported)Contact the study team to confirm eligibility.
Last Updated
October 11, 2012
Record last verified: 2012-10
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: